Home > Balance Sheet > WINDLAS BIOTECH

WINDLAS BIOTECH
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹3.20 Cr₹5.71 Cr₹14 Cr₹7.58 Cr₹0.04 Cr

What is the latest Capital Work in Progress ratio of WINDLAS BIOTECH ?

The latest Capital Work in Progress ratio of WINDLAS BIOTECH is ₹3.20 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹3.20 Cr
Mar2024₹5.71 Cr
Mar2023₹14 Cr
Mar2022₹7.58 Cr
Mar2021₹0.04 Cr

How is Capital Work in Progress of WINDLAS BIOTECH Trending?

Years Capital Work in Progress % Change
Mar2025 ₹3.20 Cr
-43.92
Mar2024 ₹5.71 Cr
-58.64
Mar2023 ₹14 Cr
82.05
Mar2022 ₹7.58 Cr
20,389.19
Mar2021 ₹0.04 Cr -

Compare Capital Work in Progress of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,626.9 Cr -2.2% -2% 2.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹167,105.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹109,088.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,120.0 Cr -1.3% 0.9% -8.9% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-2.2%

-2%

2.5%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses